Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| smooth muscle cell | 13 studies | 37% ± 17% | |
| pericyte | 10 studies | 45% ± 23% |
Insufficient scRNA-seq data for expression of RERGL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 75% | 344.40 | 1978 / 2642 | 98% | 9.53 | 693 / 705 |
| prostate | 65% | 296.10 | 159 / 245 | 78% | 3.14 | 392 / 502 |
| breast | 95% | 1242.18 | 437 / 459 | 48% | 3.42 | 534 / 1118 |
| thymus | 88% | 596.94 | 573 / 653 | 42% | 1.47 | 255 / 605 |
| uterus | 96% | 1339.85 | 163 / 170 | 22% | 1.92 | 103 / 459 |
| kidney | 61% | 403.47 | 54 / 89 | 56% | 4.10 | 507 / 901 |
| bladder | 81% | 448.19 | 17 / 21 | 19% | 1.92 | 96 / 504 |
| adipose | 93% | 1448.43 | 1124 / 1204 | 0% | 0 | 0 / 0 |
| esophagus | 67% | 348.13 | 966 / 1445 | 26% | 0.73 | 47 / 183 |
| blood vessel | 89% | 3427.92 | 1189 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 73% | 463.74 | 705 / 966 | 12% | 0.38 | 64 / 527 |
| ovary | 72% | 783.24 | 129 / 180 | 11% | 1.00 | 49 / 430 |
| adrenal gland | 22% | 72.47 | 58 / 258 | 60% | 3.51 | 138 / 230 |
| stomach | 55% | 237.73 | 198 / 359 | 26% | 0.88 | 74 / 286 |
| lung | 41% | 143.22 | 235 / 578 | 25% | 2.67 | 289 / 1155 |
| pancreas | 5% | 10.68 | 15 / 328 | 54% | 1.93 | 97 / 178 |
| skin | 48% | 252.21 | 870 / 1809 | 4% | 0.40 | 21 / 472 |
| liver | 6% | 12.56 | 14 / 226 | 45% | 1.68 | 181 / 406 |
| muscle | 35% | 104.08 | 279 / 803 | 0% | 0 | 0 / 0 |
| spleen | 27% | 70.32 | 65 / 241 | 0% | 0 | 0 / 0 |
| heart | 27% | 59.57 | 230 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.58 | 2 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.28 | 1 / 29 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005525 | Molecular function | GTP binding |
| GO_0003925 | Molecular function | G protein activity |
| Gene name | RERGL |
| Protein name | small monomeric GTPase (EC 3.6.5.2) Ras-related and estrogen-regulated growth inhibitor-like protein (EC 3.6.5.2) (RERG/Ras-like protein) |
| Synonyms | hCG_1651443 FLJ22655 |
| Description | FUNCTION: Binds GDP/GTP and may possess intrinsic GTPase activity. . |
| Accessions | ENST00000538724.6 ENST00000229002.6 Q9H628 ENST00000536890.1 F5H686 G5EA41 |